XML 20 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:    
Net loss $ (3,678,082) $ (3,410,899)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 16,475 17,547
Stock option compensation expense 61,186 57,291
Share-based compensation - common stock 2,125 4,038
Common stock and warrants to consultants 213,800 85,200
Bad debt expense $ 41 216,505
Unrealized gain on derivative instrument (14,231)
Debt discount amortization $ 402,918 217,323
Noncash finance charges 17,591
Loss on conversion of notes $ 2,588 63,867
Loss on settlement of note and warrant 132,301
Changes in assets and liabilities:    
Receivables $ (30,803) (75,494)
Prepaid expenses and other current assets 195,068 (187,935)
Inventory 90,000 160,000
Accounts payable, accrued expenses and other liabilities 1,207,086 1,641,927
Deferred revenue (13,286) 13,286
Net cash used in operating activities (1,530,883) (1,061,683)
Cash flows from investing activities:    
Purchases of property and equipment (4,561) (45,581)
Net cash used in investing activities (4,561) (45,581)
Cash flows from financing activities:    
Proceeds from notes payable 1,257,000 467,500
Repayment of note and warrant settlement (42,500) (242,000)
Proceeds from common stock and warrants 365,000 830,500
Net cash provided by financing activities 1,579,500 1,056,000
Net increase (decrease) in cash 44,056 (51,264)
Cash at beginning of year 5,745 57,009
Cash at end of year 49,801 $ 5,745
Supplemental Cash Flow Information    
Cash Paid for interest $ 10,000